News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Biochemistry and Molecular Genetics. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Northwestern Medicine investigators have discovered how the PD-1 protein controls essential metabolic processes in tumor cells to promote cancer growth in T-cell non-Hodgkin lymphomas, according to a study published in Nature Cancer.
Northwestern Medicine scientists have developed an engineered probiotic capable of detecting inflammatory bowel disease, according to a study published in the Proceedings of the National Academy of Sciences.
Northwestern Medicine investigators led by Ruli Gao, PhD, have developed a novel genetic sequencing tool that accelerates sequencing analysis of same-cell genotypes and phenotypes in tumors, as detailed in a study published in Nature Communications.
Navdeep Chandel, PhD, the David W. Cugell, MD, Professor of Medicine in the Division of Pulmonary and Critical Care and of Biochemistry and Molecular Genetics, has been named a recipient of the 2023 Lurie Prize in Biomedical Sciences by the Foundation for the National Institutes of Health.
- Northwestern Accepting Nominations for $250,000 Kimberly Prize in Biochemistry and Molecular Genetics08.09.2023
Northwestern University is accepting nominations for its $250,000 Kimberly Prize in Biochemistry and Molecular Genetics. The annual prize will be awarded in 2024.
Northwestern Medicine investigators have discovered that mitochondria regulate essential cellular signaling for the development of epithelial cells in the lungs, cells which are crucial for the exchange of oxygen and carbon dioxide to avoid respiratory failure, according to findings published in Nature.
Investigators led by Shana Kelley, PhD, have developed a novel approach for identifying sequences of artificial DNA with differing levels of binding to other small molecules, which could improve diagnostic monitoring for patients with chronic diseases.
Northwestern Medicine investigators have discovered a novel protein region that regulates DNA transcription elongation, suggesting a new therapeutic target for treating cancers and developmental disorders, according to findings published in Molecular Cell.
Northwestern Medicine scientists have identified a novel vulnerability in a subset of genes commonly mutated in cancer, according to a study recently published in The Journal of Clinical Investigation.
Northwestern Medicine scientists have shed new light on how the deadliest form of thyroid cancer becomes more aggressive, according to research published in the Journal of Clinical Investigation.
Northwestern University scientists have discovered it is possible to isolate a tumor’s attack cells non-invasively from blood, rather than from tumors.
Jennifer A. Doudna, PhD, the Li Ka Shing Chancellor’s Chair and professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley, delivered the inaugural Kimberly Prize in Biochemistry and Molecular Genetics Lecture to Feinberg faculty, staff and students on Tuesday, April 4.
Two therapeutic drugs benefited mice with non-small cell lung cancer, potentially paving the way for clinical trials in humans.
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
Northwestern Medicine scientists have identified a gene that plays a role in cellular responses to molecular stressors, such as DNA damage and nutrient scarcity.
At Feinberg, scientists are pursuing synthetic biology research to address the health challenges and diseases that humans face.
Northwestern Medicine scientists have identified a gene that is responsible for activating an aggressive subtype of small-cell lung cancer for which there is no current effective treatment.
The Kimberly Querrey Summer Research Program combines intensive, hands-on biomedical research training with academic and professional development opportunities to support the next generation of scientists.
Patients with acute myeloid leukemia show large-scale genomic mutations and altered DNA folding patterns that could help identify potential therapeutic targets, according to a Northwestern Medicine study published in Nature.
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.
Investigators discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study.